| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |